Article Details

Synaffix and Amgen sign agreement for advanced ADCs development

Retrieved on: 2023-01-06 09:56:10

Tags for this article:

Click the tags to see associated articles and topics

Synaffix and Amgen sign agreement for advanced ADCs development. View article details on hiswai:

Excerpt

... select toxSYN linker-payloads, and GlycoConnect ADC technologies. ... and GlycoConnect ADC technology platforms for a single ADC programme.

Article found on: www.pharmaceutical-technology.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up